David Mark Pritchard

This paper presents a multi-scale agent-based model of intestinal crypt dynamics, showing how signaling pathways and feedback loops govern homeostasis, injury, and recovery.

This study identifies clarithromycin as a potential therapeutic for inflammatory bowel disease through in-silico drug repositioning and experimental validation of its effects on NF-κB signaling.